F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine​

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine​

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine​

 Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.  

Creator: The New York Times (NYTHealth)

Related Posts

Green Growth Cities Are Becoming Richer and Cleaner
Green Growth Cities
Airborne Environmental DNA Is Transforming Wildlife Research
Airborne Environmental DNA
Wildlife Habitat Protection in a Rapidly Changing World
Wildlife Habitat Protection

Most Recent

Spheres of Focus

Infectious Diseases

Climate & Disasters

Food &
Water

Natural
Resources

Built
Environments

Technology & Data

Featured Posts